Eli Lilly (NYSE: LLY) has emerged as one of the hottest stocks in the GLP-1 realm -- underscored by its combination of ...

A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control ...

The results come just a few weeks after a once-weekly injectable GLP-1 drug CT-388 – also sourced ... one of a lengthening list of pharma companies that are hoping to hit on effective 'me ...

Researchers say payers should take the added costs of drugs prescribed to deal with GLP-1 side effects into account when ...

If you’re looking into weight loss drugs, liraglutide has no doubt popped up. It’s a diabetes and weight loss medication sold ...

The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain ...

The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list.

In this article, you can learn about the rights to brand-name drugs ... Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist. It’s approved by the Food and Drug Administration (FDA ...

Brands like Lemme, Arrae and Perelel are betting big on ingredients like creatine, collagen and protein, that support muscle ...

Starting next month, the Food and Drug Administration will restrict who can make and sell popular weight-loss medications known as  GLP-1s.